Mazzola Francesco, Gupta Ruta, Luk Peter P, Palme Carsten, Clark Jonathan R, Low Tsu-Hui Hubert
Department of Otorhinolaryngology and Head and Neck Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Department of Head and Neck Surgery, Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.
Head Neck. 2019 Aug;41(8):2566-2573. doi: 10.1002/hed.25732. Epub 2019 Mar 5.
Fine-needle aspiration of a salivary gland lesion is a well-established diagnostic procedure that aids management decisions. Recently, the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) classification has been proposed in order to improve the reproducibility and communication in the management of salivary gland lesions.
A total of 375 patient's cytological reports collected between January 2010 and December 2017 were reviewed and reclassified according to MSRSGC and a risk of malignancy was calculated for each of the category.
The rate of malignancy in MSRSGC classification was 19.0%, 11.8%, 25.0%, 5.5%, 50.0%, 71.4%, and 94.6% for each of the category (I, II, III, IVa, IVb, V, and VI), respectively.
The MSRSGC classification is a valuable tool in everyday practice. The modified version of MSRSGC aims to improve the surgical relevance and facilitate uniform management.
涎腺病变的细针穿刺是一种成熟的诊断方法，有助于做出治疗决策。最近，为了提高涎腺病变管理中的可重复性和沟通效果，提出了涎腺细胞病理学报告米兰系统（MSRSGC）分类法。
回顾了2010年1月至2017年12月期间收集的375份患者的细胞学报告，并根据MSRSGC进行重新分类，计算每个类别的恶性风险。
MSRSGC分类中各类别（I、II、III、IVa、IVb、V和VI）的恶性率分别为19.0%、11.8%、25.0%、5.5%、50.0%、71.4%和94.6%。
MSRSGC分类法是日常实践中的一个有价值的工具。MSRSGC的修订版旨在提高手术相关性并促进统一管理。
